N

National Allergy and Asthma Research LLC | North Charleston, SC

Research site

(Unclaimed)

Location

7555 Northside Drive, North Charleston, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Dupilumab

OPN-375

Bradanicline

EVO756

Rocatinlimab

CDX-0159

BMX-010

Symbicort®

EP262

NOC-110

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 24 total trials

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

The main objective of the study is to assess efficacy and safety of dupilumab given up to 24 weeks in adults with CPUO.This is a master protocol whic...

Enrolling

Pruritus

Drug: Placebo

Drug: Dupilumab

First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis (AURA-AD)

This study will test a study medicine called REGN20423 to see how effective it is in healthy participants (in Part A) and participants with atopic de...

Enrolling

Atopic Dermatitis

Healthy Volunteer

Other: Placebo

Drug: REGN20423

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Active, not recruiting

Refractory or Unexplained Chronic Cough

Drug: NOC-110

Other: Placebo